11 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Alkyl-bridged substituted 8-arylquinolines as highly potent PDE IV inhibitors.
Merck Frosst Center For Therapeutic Research
3,4-Diarylpiperidines as potent renin inhibitors.
Merck Frosst Center For Therapeutic Research
Synthesis and SAR of pyrimidine-based, non-nucleotide P2Y14 receptor antagonists.
Merck Frosst Center For Therapeutic Research
Trisubstituted ureas as potent and selective mPGES-1 inhibitors.
Merck Frosst Center For Therapeutic Research
Identification of a new biaryl scaffold generating potent renin inhibitors.
Merck Frosst Center For Therapeutic Research
Optimization and structure-activity relationship of a series of 1-phenyl-1,8-naphthyridin-4-one-3-carboxamides: identification of MK-0873, a potent and effective PDE4 inhibitor.
Merck Frosst Center For Therapeutic Research
Design, synthesis, and biological evaluation of 8-biarylquinolines: a novel class of PDE4 inhibitors.
Merck Frosst Center For Therapeutic Research
Nitrogen-bridged substituted 8-arylquinolines as potent PDE IV inhibitors.
Merck Frosst Center For Therapeutic Research
Substituted indoles as potent and orally active 5-lipoxygenase activating protein (FLAP) inhibitors.
Merck Frosst Center For Therapeutic Research
A series of non-quinoline cysLT1 receptor antagonists: SAR study on pyridyl analogs of Singulair.
Merck Frosst Center For Therapeutic Research
